These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 25406646)
1. Effects of acute exercise on pancreatic endocrine function in subjects with type 2 diabetes. Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK; Solomon TP Diabetes Obes Metab; 2015 Feb; 17(2):207-10. PubMed ID: 25406646 [TBL] [Abstract][Full Text] [Related]
2. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity. Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193 [TBL] [Abstract][Full Text] [Related]
3. A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility. Fritsche A; Stefan N; Hardt E; Schützenauer S; Häring H; Stumvoll M Eur J Clin Invest; 2000 May; 30(5):411-8. PubMed ID: 10809901 [TBL] [Abstract][Full Text] [Related]
4. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans. Christensen MB Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187 [TBL] [Abstract][Full Text] [Related]
6. Comparison of an oral mixed meal plus arginine and intravenous glucose, GLP-1 plus arginine to unmask residual islet function in longstanding type 1 diabetes. Uitbeijerse BS; Nijhoff MF; de Koning EJP Am J Physiol Endocrinol Metab; 2024 May; 326(5):E673-E680. PubMed ID: 38446636 [TBL] [Abstract][Full Text] [Related]
7. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus. Ahrén B; Larsson H; Holst JJ J Clin Endocrinol Metab; 1997 Feb; 82(2):473-8. PubMed ID: 9024239 [TBL] [Abstract][Full Text] [Related]
8. Impaired incretin secretion and pancreatic dysfunction with older age and diabetes. Geloneze B; de Oliveira Mda S; Vasques AC; Novaes FS; Pareja JC; Tambascia MA Metabolism; 2014 Jul; 63(7):922-9. PubMed ID: 24854384 [TBL] [Abstract][Full Text] [Related]
9. The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action. Hare KJ; Vilsbøll T; Asmar M; Deacon CF; Knop FK; Holst JJ Diabetes; 2010 Jul; 59(7):1765-70. PubMed ID: 20150286 [TBL] [Abstract][Full Text] [Related]
10. Albiglutide does not impair the counter-regulatory hormone response to hypoglycaemia: a randomized, double-blind, placebo-controlled, stepped glucose clamp study in subjects with type 2 diabetes mellitus. Hompesch M; Jones-Leone A; Carr MC; Matthews J; Zhi H; Young M; Morrow L; Reinhardt RR Diabetes Obes Metab; 2015 Jan; 17(1):82-90. PubMed ID: 25263215 [TBL] [Abstract][Full Text] [Related]
11. On the role of the gut in diabetic hyperglucagonaemia. Lund A Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175 [TBL] [Abstract][Full Text] [Related]
12. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells. Hamaguchi T; Fukushima H; Uehara M; Wada S; Shirotani T; Kishikawa H; Ichinose K; Yamaguchi K; Shichiri M Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438 [TBL] [Abstract][Full Text] [Related]
13. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight. Schou JH; Pilgaard K; Vilsbøll T; Jensen CB; Deacon CF; Holst JJ; Vølund A; Madsbad S; Vaag AA J Clin Endocrinol Metab; 2005 Aug; 90(8):4912-9. PubMed ID: 15899957 [TBL] [Abstract][Full Text] [Related]
14. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes. Højberg PV; Vilsbøll T; Zander M; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S Diabet Med; 2008 Nov; 25(11):1268-75. PubMed ID: 19046215 [TBL] [Abstract][Full Text] [Related]
15. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus. Hare KJ Dan Med Bull; 2010 Sep; 57(9):B4181. PubMed ID: 20816021 [TBL] [Abstract][Full Text] [Related]
16. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1. Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561 [TBL] [Abstract][Full Text] [Related]
17. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877 [TBL] [Abstract][Full Text] [Related]
18. The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia. Gjessing HJ; Reinholdt B; Pedersen O Diabetologia; 1989 Dec; 32(12):858-63. PubMed ID: 2693165 [TBL] [Abstract][Full Text] [Related]
19. Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes. Hansen JS; Pedersen BK; Xu G; Lehmann R; Weigert C; Plomgaard P J Clin Endocrinol Metab; 2016 Jul; 101(7):2816-25. PubMed ID: 27163358 [TBL] [Abstract][Full Text] [Related]
20. Pulsatile insulin secretion in elderly patients with diabetes. Meneilly GS; Veldhuis JD; Elahi D Diabetes Res Clin Pract; 2006 Aug; 73(2):218-20. PubMed ID: 16621106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]